UnknownNot Applicable

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

China150 participantsStarted 2010-10

Plain-language summary

To evaluate the values of portosystemic shunt and other interventional radiology approaches for treatment of symptomatic portal hypertension in patients with cavernous transformation of portal vein.

Who can participate

Age range1 Year – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with portal hypertention who have enough image information to confirm cavernous transformation of portal vein. Exclusion Criteria: * Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs.

What they're measuring

Incidence Rate of Gastrointestinal Bleeding

Timeframe: 1 month

Ascites Volume (mL)

Timeframe: 1 month

Trial details

NCT IDNCT02504034

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12

Contact for this trial

Zaibo Jiang, MD.

+86 020 85252066 jiangzaibo@aliyun.com

View on ClinicalTrials.gov More Portal Vein, Cavernous Transformation Of trials